Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“AMRX continues to dominate the new approval and launch ranks and remains the best positioned organic growth play in the sector"
When I worked in the pharmacy, I learned how picky patients can be when it comes to which generic manufacturer they prefer
When I worked in wholesale, I learned you could sell Amneal products to pharmacies and not get a bunch of backlash from patients demanding a different manufacturer.
Hello AMRX! And Hello Shorty! Seems AMRX is undervalued but muddled by the Impax/Global buyout last year. Anyways, welcome to the board, let's see if we can get back to $20+ in 2019